Leverage Shares 2X Long CBRS Daily ETF
CBRG
Chicago Board Options Exchange8.85
USD
-1.64
- -
Leverage Shares 2X Long CBRS Daily ETF
CBRG
(Chicago Board Options Exchange)
Recent
price
8.85
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Chain Bridge I (CBRG) operates as a blank check company, or special purpose acquisition company (SPAC), whose primary purpose is to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or assets. The company offers no operating products or services of its own, instead focusing exclusively on identifying and executing de-SPAC transactions to bring target companies public; its core activities encompass due diligence, shareholder approvals, proxy filings, trust management, and post-merger integration support for targets in sectors such as biotechnology, commercial real estate technology, and financial services. Founded in 2021 and headquartered in Dover, Delaware, with operational offices in Burlingame, California, Chain Bridge I conducts its activities primarily in the United States, targeting innovative private companies seeking public market access via Nasdaq or OTC markets. In recent developments, Chain Bridge I signed a non-binding letter of intent in September 2025 with CommLoan, a commercial mortgage technology provider, to pursue a business combination that would create a new public entity focused on disrupting the commercial real estate lending marketplace through advanced fintech solutions; the deal values CommLoan at a $50 million pre-money equity level and anticipates a definitive agreement in Q4 2025 with closing in the first half of 2026, pending shareholder approvals. Earlier pursuits included a proposed merger with Phytanix Bio for cannabinoid therapeutics, which faced Nasdaq delisting in late 2024 leading to a shift to OTCQB trading under CBRRF, alongside a prior non-binding deal that progressed to OTC Pink markets. To support ongoing operations and extend its merger timeline, the company secured $1 million in gross proceeds from a discounted convertible promissory note private placement with C/M Capital Master Fund in September 2025, and entered a contribution agreement with Fulton AC I LLC in late September 2025 for up to approximately $54,688 in trust deposits tied to shareholder votes on deadline extensions. These moves reflect Chain Bridge I's strategic efforts to navigate regulatory hurdles, maintain liquidity post-IPO in November 2021, and advance toward a viable business combination amid a competitive SPAC landscape.
Two Burritos Brings Authentic Mexican Street Food To Fairfax City
Phytanix Bio Publishes New Investor Deck Highlighting Strategic Vision and Growth Potential
Phytanix Bio Publishes New Investor Deck Highlighting Strategic Vision and Growth Potential